About Us

Designed for sponsors, ready for CRO collaboration.

Physicians and trial sponsor cooperation

Our Principles

DexTrial operates on the foundational principles of ethical research and operational excellence. We are committed to building a secure, compliant, and transparent ecosystem that empowers physicians, protects patients, and delivers high-fidelity data to clinical sponsors.

01

Transparency and Trust

Ensuring complete visibility across the referral lifecycle. We foster trust through clear communication, predictable processes, and real-time operational insights for all stakeholders.

02

Regulatory Compliance

Built to meet the highest industry standards. Our platform and processes strictly adhere to GCP, GDPR, and regional healthcare regulations, mitigating compliance risks for sponsors and clinical sites.

03

Data Safety and Integrity

Safeguarding sensitive health information with enterprise-grade architecture. We ensure the secure transmission and strict access control of all pre-screening data to prevent breaches and guarantee trial validity.

Continuous Feedback Loop

At DexTrial we listen to the customer needs and elaborate tailored recruitment strategy with the highest outreach. Our campaigns are governed by performance monitoring and adjusted upon need to get effective recruitment results for the clinical trial sponsors.

Learn More

Your Requirements

Our Deliverables

DexTrial Team

Founders

Georg Avakyan

CEO and Co-Founder

Georg is a pharmaceutical specialist with eager drive to bring clinical operations and digital health forward. His experience includes oncology trial coordination in Switzerland, AI‑enabled clinical research, and portfolio analysis at EVER Pharma. He brings strategic and digital leadership to the DexTrial team.

Kirill Mamontov

CTPO and Co-Founder

Kirill is a clinical operations expert with strong competence in digital product development and regulatory‑compliant trial execution. At PSI, he coordinated multinational studies, ensuring GCP adherence and operational consistency. At DexTrial, he drives platform development and regulatory‑aligned product delivery.

Anastasija Kikase

COO and Co-Founder

Anastasija is a biotech operations leader specializing in digitalization and compliance. She has modernized enterprise systems and managed regulatory inspections at CureVac and GBA Pharma. As a former operations director of a multimillion‑euro wholesaler, she brings entrepreneurial rigor and strong governance to DexTrial's team.

Team

People that help advancing medical research on a daily basis.

Anton is a lead software engineer specializing in large‑scale data processing and high‑performance backend development. At Yandex, he built and optimized mission‑critical systems and robust data pipelines. With a strong mathematical background, he brings analytical rigor and engineering leadership to DexTrial's technical evolution.

Anton Pichushkin

Lead Software Engineer

Rebeca is a sales specialist with experience advising physicians, clinics, and purchasers on digital products, process optimization, and clinical‑use workflows at the medical start‑up BabyBe. With a background in anesthesia nursing and health consulting, she combines clinical insight with strong customer engagement skills.

Rebeca Rat

Sales Representative

Yeliz is an experienced QA professional, testing digital health applications, improving defect lifecycles, and expanding test coverage using diverse tools. With hands‑on agile development experience and a biomedical engineering background, she ensures product quality, usability, and regulatory‑aligned workflows for DexTrial technology.

Yeliz Oguz

Associate QA Manager

Our Trusted Advisors

Advisors that support us with complex clinical trial design and strategy setup.

Friedrich Kursten is a seasoned veteran of the clinical trials industry. With decades of experience in CROs and as former Senior Vice President of Clinical Operations at Octapharma, he has overseen numerous clinical development programs. His operational expertise and hands‑on approach guide DexTrial's operational strategy.

Friedrich Kursten

Clinical Operations & Technical Advisor

Chris Heubeck is a business strategist with extensive experience in strategic transformation at UBS, supported by previous roles at BCG, KPMG, and DATEV. With an MBA from the University of St. Gallen and strong expertise in digital strategy and innovation, he provides strategic, operational, and transformation guidance to DexTrial.

Christoph Heubeck

Business & Finance Advisor

Dominic Jud is a regulatory affairs expert with over 10 years at Novo Nordisk, where he served as Global Regulatory Lead for blockbuster biologics in obesity and cardiovascular disease. Now Director of Regulatory Strategy at BridgeBio and a lecturer at ETH Zürich, he brings deep global regulatory, compliance, and lifecycle‑management expertise to DexTrial.

Dominic Jud

Regulatory & Compliance Advisor

With over 25 years in the pharmaceutical and biotech industries, Dr. Thibaut has held several senior roles, including Member of the Supervisory Board at Glycotope GmbH and Member of the Board of R&D at Octapharma. He brings deep research expertise and strategic leadership to support DexTrial's long‑term growth.

Dr. Ulrich Thibaut

Scientific & Strategy Advisor

Dr. Skrahina is a medical affairs expert with extensive experience leading global clinical studies, advancing evidence generation, and collaborating with KOLs in rare and genetic diseases. She has built accredited diagnostic systems and driven cross‑functional strategy for companies including Rhythm Pharmaceuticals, Arcensus, and Centogene.

Dr. Volha Skrahina

Medical Advisor

Where to find us

Get in Touch
with Us

Please direct your inquiries to our team using the form below. We are dedicated to assisting partners, physicians, and patients with their specific clinical research needs.

Your Name

Your Email

Your Phone

Your Inquiry

By submitting this form, you consent to the processing of your Personal data.